【ChiCTR2000034585】World Health Organization Caregiver Skills Training (WHO-CST) Programme for Hong Kong Chinese families of young children with developmental delays or Autism Spectrum Disorders– Phase Three: evaluation of the pilot implementation
ChiCTR2000034585
正在进行
/
/
/
2020-07-11
/
/
疑似自閉症譜系障礙和發育遲緩
World Health Organization Caregiver Skills Training (WHO-CST) Programme for Hong Kong Chinese families of young children with developmental delays or Autism Spectrum Disorders– Phase Three: evaluation of the pilot implementation
World Health Organization Caregiver Skills Training (WHO-CST) Programme for Hong Kong Chinese families of young children with developmental delays or Autism Spectrum Disorders– Phase Three: evaluation of the pilot implementation
This study aimed to examine the effectiveness of the adapted WHO-CST intervention in the local settings. The specific objectives of the study are: 1) to examine the effectiveness of WHO-CST programme in Hong Kong context; 2) to examine potential factors influencing the effectiveness of WHO-CST programme in Hong Kong context
随机平行对照
其它
The research team will randomly assign participants into 12 groups, as well as condition.
/
Charities Trust
/
60
/
2020-09-01
2021-07-31
/
The caregiver-child dyads will be recruited if they fulfilled the following inclusion criteria: For caregivers, they should be; 1. At least 18 years or above; 2. the primary caregiver who is responsible for the role of parenting the child, this could be biological parent (father or mother), guardian or other adult family member (i.e., the same caregiver who will attend the WHO-CST programme if s/he agrees); 3. living together with the target child; 4. able to communicate in Cantonese; 5. able to read and write basic Chinese; 6. planned to stay in Hong Kong for at least six months for most of the time for home visits and 9 sections of face-to-face group intervention and accessible by phone; Additionally, to ensure the adherence of WHO-CST programme, these caregivers shall allow the following procedures to be carried out during the programme implementation: 1. allow three home visits by facilitators who deliver the programme (World Health Organization, 2016). These MTs would be the professionals or para-professionals from HKU, governmental bodies and/or NGOs, and 2. agree to take videos for research purposes. The video-recording will take place on three home visits and 9 sections of face-to-face group intervention. For children, they should be: 1. between 2 and 6 years old; 2. screened positive on Chinese version of the Checklist for Autism in Toddlers (C-CHAT-23) Wong et al. (2004) or 3. suspected to display symptoms or behaviours of autism spectrum disorder, such as persistent deficits in social communication and social interaction across multiple contexts and restricted, repetitive patterns of behaviours, interest, or activities; 4. suspected to display symptoms or behaviours of communication disorder, such as persistent difficulties in the acquisition and use of language across modalities and language abilities are substantially and quantifiably below those expected age; 5. the above symptoms or behaviours are the primary concerns of developmental issues the child face as reported by caregivers or clinicians (children who are suspected to co-morbid other conditions, such as intellectual disability, attention deficit hyperactivity disorder, specific learning disorder, motor disorder are also eligible if these other conditions are not primary concerns of developmental issues).;
请登录查看Caregivers will be excluded if they fulfil the following criterion: Physical or mental condition that required hospitalization or frequent outpatient visits (e.g., three visits for 6 months). Children will be excluded if they fulfil one of the following criteria; 1. Deafness or blindness in the child; 2. Co-morbid physical and mental conditions that the child is now hospitalized; 3. Co-morbid motor skill developmental delays, physical disabilities or motor disorders, including stereotypic movement disorder, tic disorder, and other.;
请登录查看Hong Kong Jockey Club Charities Trust
/
Hong Kong Jockey Club Charities Trust的其他临床试验
- Effects of a multicomponent intervention on functional ability in community-dwelling older people: a randomized controlled trial
- Effectiveness of post hospital discharge support program to improve the well-being of people with dementia and family caregivers
- Unpacking the concept of physical literacy to support children's physical literacy journey: a parent-focused intervention
- World Health Organization Caregiver Skills Training (WHO-CST) Programme for Hong Kong Chinese families of young children with developmental delays or Autism Spectrum Disorders– Phase Three: evaluation of the pilot implementation
- Community eHealth Care Project
- Effectiveness of a dementia friendly program and bluetooth tracking technology to enhance public knowledge and attitude on dementia and reduce caregiver anxiety on getting lost
香港大學社會科學學院的其他临床试验
- “厨厨有爱”:新来港人士社区融合计划
- Randomized controlled trial of Enhancing Contact Model on reducing stigma of mental illness in family caregivers of persons with schizophrenia in rural China
- World Health Organization Caregiver Skills Training (WHO-CST) Programme for Hong Kong Chinese families of young children with developmental delays or Autism Spectrum Disorders– Phase Three: evaluation of the pilot implementation
最新临床资讯
-
大鹏制药临床III期成功
新药说2026-08-13
-
新一代 EGFR-TKI 首个全球 III 期成功
丁香园 Insight 数据库2026-08-13
-
体外诊断原料网2026-08-13
-
佰傲谷BioValley2026-08-13
-
久有基金2026-08-13
-
重庆宸安生物2026-08-13
-
UmabsDB2026-08-13
-
希格生科2026-08-13
-
bioSeedin柏思荟2026-08-13
-
智飞智讯2026-08-13
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 20 8
-
摩熵咨询 34 28
-
摩熵咨询 20 5
-
颁布机构:四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构:国家医保局 2026-07-31
-
颁布机构:国家药品审评中心(CDE) 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 35 36
-
摩熵咨询 28 39
-
摩熵咨询 34 18
-
颁布机构:国家市场监督管理总局 2026-08-10
-
颁布机构:国家市场监督管理总局 2026-05-29
-
颁布机构:国家市场监督管理总局 2026-05-29
